Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for SWDCF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2015. Start Trial.
Date Value
March 31, 2026 1.023B
December 31, 2025 1.032B
September 30, 2025 1.021B
June 30, 2025 1.026B
March 31, 2025 976.96M
December 31, 2024 933.67M
September 30, 2024 945.85M
June 30, 2024 948.13M
March 31, 2024 946.83M
December 31, 2023 944.85M
September 30, 2023 941.42M
June 30, 2023 955.86M
March 31, 2023 953.98M
December 31, 2022 960.19M
September 30, 2022 933.80M
June 30, 2022 949.01M
March 31, 2022 958.74M
December 31, 2021 383.39M
September 30, 2021 379.05M
June 30, 2021 307.78M
March 31, 2021 152.76M
December 31, 2020 141.74M
September 30, 2020 78.99M
Date Value
June 30, 2020 30.67M
March 31, 2020 16.22M
December 31, 2019 15.96M
September 30, 2019 14.73M
June 30, 2019 14.87M
March 31, 2019 14.34M
December 31, 2018 13.29M
September 30, 2018 12.98M
June 30, 2018 12.49M
March 31, 2018 12.59M
December 31, 2017 12.20M
September 30, 2017 12.26M
June 30, 2017 11.40M
March 31, 2017 10.61M
December 31, 2016 9.881M
September 30, 2016 7.765M
June 30, 2016 7.266M
March 31, 2016 4.109M
December 31, 2015 2.210M
September 30, 2015 2.279M
June 30, 2015 2.085M
March 31, 2015 1.539M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
Orexo AB 64.08M
Camurus AB 520.47M
Moberg Pharma AB 71.75M
Infant Bacterial Therapeutics AB 15.02M
AstraZeneca PLC 114.02B

Total Assets (Quarterly) Related Metrics